StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mizuho Securities Reiterates Buy Rating on Pfizer (PFE) Ahead of 1Q Report
April 27, 2020 6:44 AM
Mizuho Securities analyst Vamil Divan reiterated a Buy rating and $42.00 price target on Pfizer (NYSE: PFE) ahead of the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Pfizer (PFE), BioTech (BNTX) Report Complete Patient Dosing in First Cohort of Ph. 1/2 Trial of COVID-19 vaccine candidates in Germany
April 29, 2020 5:48 AM
Special Report: Countries, companies risk billions in race for coronavirus vaccine
April 25, 2020 3:37 PM
Pfizer Hosts Virtual-Only Annual Meeting of Shareholders
April 23, 2020 1:54 PM
Centogene Reports Financial Results For Full Year 2019 and Highlights Recent Progress
April 23, 2020 6:31 AM
Centogene Reports Financial Results For Full Year 2019 and Highlights Recent Progress
April 23, 2020 6:30 AM
